Observational study reports 82.4% adherence to LTBI treatment in 34 patients, indicating sociodemographic factors influence outcomes.
Introduction: The high prevalence and incidence of LTBI in the world means that the disease has not yet been eradicated. Even though the treatment is already consolidated, few studies on drug adherence in LTBI have been developed. This study investigates adherence to pharmacological treatment of LTBI in users treated at health units in a location in Salvador, Bahia, Brazil. Methods: observational cross-sectional study, using a sociodemographic and clinical questionnaire and an adapted Morisky -Green adherence test. Results: 34 patients with LTBI participated. The majority of users adhere to pharmacotherapy (82.4%; N=24). And a small number are few adherents 17.6% (N=6). No non-compliant users were found. Adherence to LTBI treatment is related to selected sociodemographic and clinical variables: appearance of ADRs (p =0.031); difficulties in taking medications (p=0.020); and participation in tuberculosis groups (p =0.043). Conclusion: there is a need to better conduct LTBI treatment in the Salvador Railway Suburb. F uture research is valid to deepen this study. A protocol and/or flow is suggested to promote adherence of people with LTBI.
No takes yet. Share an insight, caveat, or question.
M Ramos (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: